Compare SPT & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SPT | DNA |
|---|---|---|
| Founded | 2010 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 633.9M | 562.3M |
| IPO Year | 2019 | N/A |
| Metric | SPT | DNA |
|---|---|---|
| Price | $11.35 | $8.11 |
| Analyst Decision | Buy | Strong Sell |
| Analyst Count | 10 | 1 |
| Target Price | ★ $26.00 | $9.00 |
| AVG Volume (30 Days) | ★ 1.1M | 1.0M |
| Earning Date | 11-05-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $443,750,000.00 | $180,606,000.00 |
| Revenue This Year | $13.30 | N/A |
| Revenue Next Year | $11.37 | $7.28 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 13.09 | N/A |
| 52 Week Low | $9.16 | $5.00 |
| 52 Week High | $35.18 | $17.58 |
| Indicator | SPT | DNA |
|---|---|---|
| Relative Strength Index (RSI) | 60.16 | 35.56 |
| Support Level | $10.50 | $8.17 |
| Resistance Level | $11.47 | $8.90 |
| Average True Range (ATR) | 0.48 | 0.59 |
| MACD | 0.11 | -0.00 |
| Stochastic Oscillator | 66.16 | 1.01 |
Sprout Social Inc develops a cloud software that brings together social messaging, data and workflows in a unified system of record, intelligence, and action. It has a centralized, secure and powerful platform that can scale horizontally across an organization to drive maximum business value. The firm generates majority revenue from software subscriptions.
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.